Russian
French
 
 
-ISO 9001:2000
   
 

Intraoral Drug Delivery

Intra oral drug delivery provides an excellent route of drug delivery into systemic circulation. It has inherent advantages such as prompt onset of action & predictable drug delivery.

Breakthrough Pain (BTP) occurs once or more times a day to terminally ill cancer patients and severely compromises their quality of life. The need of the hour is a drug delivery that provides prompt and potent onset of action for each episode of BTP.

Trofentyl OTFC, is a lozenge of Fentanyl Citrate for the treatment of breakthrough pain. As soon as the patient rolls the lozenge in his/her oral cavity, the drug released from the lozenge gets absorbed from the oral mucosa . The pain relief starts in about 10-12 minutes and lasts for 20-25 minutes. In the event the patient experiences any adverse effects, he/she can simply take the lozenge out and the effect will wear off  in a few minutes.

There are several other products manufactured using proprietary Intra Oral drug delivery technology viz. nitroglycerine, short acting benzodiazepines, an NSAID etc.

 

back to Innovative Technologies

 
- - -
Overview
AquaTech
Decompaction
DrySolve
Duophase
IFC
Intraoral Drug Delivery
Lipisol
LipoTech
LiquiCaps
Matrix
Maxisorb
Microsolve
Mucogrip
Organogel
Parenteral Nano Emulsion
Pre Filled Syringes (PFS)
Quick Penetrating Solution (QPS)
SoluTech
 

Products manufactured using Intraoral Drug Delivery:

Oral Transmucosal Fentanyl Citrate & Lidocaine Lozenge

 
Oral Transmucosal Fentanyl Citrate
Trofentyl OTFC
 
 
::: Research Publications: Trofentyl OTFC
 
::: Research Publications: Xynova 200
 
 
   

Home | Company | Products | Technologies | International Business | Media Coverage | Human Resources | Research Publications | Partnering

Copyright ę 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer